NANT XL Trademark

Trademark Overview

On Friday, June 29, 2018, a trademark application was filed for NANT XL with the United States Patent and Trademark Office. The USPTO has given the NANT XL trademark a serial number of 88021314. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, February 13, 2023. This trademark is owned by Nant Holdings IP, LLC. The NANT XL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research consultation services and research and development services, both of the aforementioned services being in the field of hematology, immunology, cancer research, developmental biology and life science, biotechnology, medical technology, cell culture, tissue engineering, regenerative medicine, immunotherapy, immunomodulation, control of inflammation and of the immune system, vaccine production, and viral vectors production; biopharmaceutical development and research and evaluation services in the field of stem cell-based therapeutics for the treatment of disease, injuries and disorders; biotechnology laboratory services; scientific laboratory services in the field of cell expansion technology for derivation, expansion, transformation, and multiplication of cells; experimental and research services in the fields of diagnostic processes and therapeutic applications for therapy of osteoarthritis for human or veterinary applications in laboratory, industrial or clinical centers
nant xl

General Information

Serial Number88021314
Word MarkNANT XL
Filing DateFriday, June 29, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, February 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2019

Trademark Statements

Goods and ServicesResearch consultation services and research and development services, both of the aforementioned services being in the field of hematology, immunology, cancer research, developmental biology and life science, biotechnology, medical technology, cell culture, tissue engineering, regenerative medicine, immunotherapy, immunomodulation, control of inflammation and of the immune system, vaccine production, and viral vectors production; biopharmaceutical development and research and evaluation services in the field of stem cell-based therapeutics for the treatment of disease, injuries and disorders; biotechnology laboratory services; scientific laboratory services in the field of cell expansion technology for derivation, expansion, transformation, and multiplication of cells; experimental and research services in the fields of diagnostic processes and therapeutic applications for therapy of osteoarthritis for human or veterinary applications in laboratory, industrial or clinical centers

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 6, 2018
Primary Code042
First Use Anywhere DateFriday, May 31, 2019
First Use In Commerce DateFriday, May 31, 2019

Trademark Owner History

Party NameNant Holdings IP, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCulver City, CA 90232
Party NameNant Holdings IP, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCulver City, CA 90232

Trademark Events

Event DateEvent Description
Monday, February 13, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, February 13, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, February 13, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, August 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 1, 2022NON-FINAL ACTION E-MAILED
Monday, August 1, 2022SU - NON-FINAL ACTION - WRITTEN
Tuesday, July 5, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 30, 2022USE AMENDMENT FILED
Thursday, June 30, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, January 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 12, 2022SOU EXTENSION 5 GRANTED
Monday, January 3, 2022SOU EXTENSION 5 FILED
Wednesday, January 12, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 3, 2022TEAS EXTENSION RECEIVED
Tuesday, July 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 2, 2021SOU EXTENSION 4 GRANTED
Friday, July 2, 2021SOU EXTENSION 4 FILED
Friday, July 2, 2021TEAS EXTENSION RECEIVED
Tuesday, January 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, January 3, 2021SOU EXTENSION 3 GRANTED
Sunday, January 3, 2021SOU EXTENSION 3 FILED
Sunday, January 3, 2021TEAS EXTENSION RECEIVED
Saturday, June 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 25, 2020SOU EXTENSION 2 GRANTED
Thursday, June 25, 2020SOU EXTENSION 2 FILED
Thursday, June 25, 2020TEAS EXTENSION RECEIVED
Friday, December 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 18, 2019SOU EXTENSION 1 GRANTED
Wednesday, December 18, 2019SOU EXTENSION 1 FILED
Wednesday, December 18, 2019TEAS EXTENSION RECEIVED
Friday, August 16, 2019ASSIGNED TO EXAMINER
Tuesday, July 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 25, 2019ASSIGNED TO LIE
Tuesday, March 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 27, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 26, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 26, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 27, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 27, 2018NON-FINAL ACTION E-MAILED
Monday, August 27, 2018NON-FINAL ACTION WRITTEN
Thursday, August 16, 2018ASSIGNED TO EXAMINER
Friday, July 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 3, 2018NEW APPLICATION ENTERED

Related Keywords

nant services research cell field laboratory technology applications expansion biotechnology production